Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients.
Christine NitschkeBenedikt MarkmannMarie TölleJolanthe KropidlowskiYassine BelloumMara R GoetzHartmut SchlüterMarcel KwiatkowskiMarianne SinnJakob IzbickiKlaus PantelCenap GüngörFaik G UzunogluHarriett WikmanPublished in: Cancers (2022)
CTC detection in resected PDAC patients during FUP is associated with a worse prognosis, and RARRES1 expression might identify an aggressive subtype of CTCs that deserves further investigation.